Lumos Diagnostics Holdings Ltd. (AU:LDX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lumos Diagnostics Holdings Limited has announced a new proposal to issue a total of 62,196,034 unlisted options at an exercise price of $0.07, expiring on September 30, 2026. The proposed issue date is set for October 9, 2024. This strategic move aims to strengthen the company’s financial position and secure long-term growth.
For further insights into AU:LDX stock, check out TipRanks’ Stock Analysis page.